-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Yabao Pharmaceutical's announcement, the purpose of the company's share repurchase is to cancel all shares and reduce registered capital. The repurchase period is from August 18, 2026 to August 17, 2027. The estimated repurchase amount is 100 million yuan to 200 million yuan. The upper limit of the repurchase price was adjusted to 6.75 yuan/share due to semi-annual equity distribution. As of November 20, 2026, the company had repurchased a total of 14.18 million shares through centralized bidding transactions, accounting for 2.05% of the total share capital. The repurchase price range was 6.26 yuan/share - 6.74 yuan/share, and the total payment amount was 91.9489 million yuan. Subsequent companies will take the opportunity to promote the repurchase within the repurchase period.

Zhitongcaijing·11/20/2026 07:49:10
Listen to the news
According to Yabao Pharmaceutical's announcement, the purpose of the company's share repurchase is to cancel all shares and reduce registered capital. The repurchase period is from August 18, 2026 to August 17, 2027. The estimated repurchase amount is 100 million yuan to 200 million yuan. The upper limit of the repurchase price was adjusted to 6.75 yuan/share due to semi-annual equity distribution. As of November 20, 2026, the company had repurchased a total of 14.18 million shares through centralized bidding transactions, accounting for 2.05% of the total share capital. The repurchase price range was 6.26 yuan/share - 6.74 yuan/share, and the total payment amount was 91.9489 million yuan. Subsequent companies will take the opportunity to promote the repurchase within the repurchase period.